Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 59-65

  Herfarth, Hans ^a,c   Brand, K ^b   Rath, H C ^a   Rogler, G ^a   Scholmerich J ^a   Falk, W ^a  

^a Department of Internal Medicine I ^*  (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

DSS colitis; Gliotoxin; NF B

Indexed keywords

DEXTRAN SULFATE; GLIOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENTERITIS; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034024741     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01184.x     Document Type: Article

References (48)

1. Dieleman LA, Ridwan BU, Tennyson GS et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52.
2. Elson CO, Sartor RB, Tennyson GS et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344-67.
3. Arai Y, Takanashi H, Kitagawa H et al. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 1998; 10:890-6.
4. Strober W, Fuss IJ, Ehrhardt RO et al. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 1998; 48:453-8.
5. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998; 22:382-9.
6. Rutgeerts P. Medical therapy of inflammatory bowel disease. Digestion 1998; 59:453-69.
7. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut 1998; 42:477-84.
8. Neurath MF, Petterson S, Meyer zum Büschenfelde KH et al. Local administration of antisense phosphorothiotate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996; 2:998-1004.
9. Rogler G, Brand K, Vogel D et al. Nuclear factor-kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998; 115:357-69.
10. Baldwin As Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-83.
11. Conner EM, Brand S, Davis JM et al. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM- 1 transcription and the development of chronic colitis. J Pharmacol Exp Ther 1997; 282:1615-22.
12. Mullbacher A, Waring P, Tiwari-Palni U et al. Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol Immunol 1986; 23:231-5.
13. Waring P, Beaver J. Gliotoxin and related epipolythiodioxopiperazines. Gen Pharmacol 1996; 27:1311-6.
14. Mullbacher A, Eichner RD. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci USA 1984; 81:3835-7.
15. Murayama T, Amitani R, Ikegami Y et al. Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur Respir J 1996; 9:293-300.
16. Pahl HL, Krauss B, Schulze OK et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183:1829-40.
17. Kojouharoff G, Hans W, Obermeier F et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997; 107:353-8.
18. Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 1982; 60:618-22.
19. Herfarth HH, Mohanty SP, Rath HC et al. Interleukin-10 suppresses chronic granulomatous inflammation induced by bacterial cell wall polymers in a rat model. Gut 1996; 39:836-45.
20. Khandjian EW, Meric C. A procedure for Northern blot analysis of native RNA. Anal Biochem 1986; 159:227-32.
21. Khandjian EW. UV crosslinking of RNA to nylon membrane enhances hybridization signals. Mol Biol Rep 1986; 11:107-15.
22. Brand K, Page S, Rogler G et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996; 97:1715-22.
23. Sutton P, Newcombe NR, Waring P et al. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 1994; 62:1192-8.
24. Eichner RD, Al Salami M, Wood PR et al. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol 1986; 8:789-97.
25. Malizia G, Calabrese A, Cottone M et al. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991; 100:150-9.
26. Schuermann GM, Aber BA, Facer P et al. Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol 1993; 94:341-7.
27. Grimm MC, Elsbury S, Pavli P et al. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996; 38:90-98.
28. Daig R, Andus T, Aschenbrenner E et al. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1995; 38:216-22.
29. Mazzucchelli L, Hauser C, Zgraggen K et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol 1996; 178:201-6.
30. Reinecker H-C, Loh EY, Ringler DJ et al. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995; 108:40-50.
31. Plevy SE, Landers CJ, Prehn J et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159:6276-82.
32. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 1989; 30:835-8.
33. Okayasu I, Hatakeyma S, Yamada M et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694-702.
34. Mahler M, Bristol IJ, Leiter EH et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 1998; 274:G544-G551.
35. Blackburn AC, Doe WF, Buffinton GD. Colonic antioxidant status in dextran sulfate-induced colitis in mice. Inflamm Bowel Dis 1997; 3:198-203.
36. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
37. Herfarth H, Rath HC, Hofmeister R et al. In vivo treatment with the fungal metabolite gliotoxin suppresses intestinal inflammation in dextran sulphate sodium [DSS]-induced colitis. Gastroenterology 1998; 114:A993(Abstr.).
38. Herfarth H, Brand K, Rogler G et al. Immunosuppressive effect of treatment with the fungal metabolite gliotoxin in dextran sulphate sodium [DSS]-induced colitis. Gastroenterology 1999; 116:A3086(Abstr.).
39. Neurath MF, Petterson S. Predominant role of NF-B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiol 1997; 198:91-98.
40. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-71.
41. Jobin C, Panja A, Hellerbrand C et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol 1998; 160:410-8.
42. Jobin C, Hellerbrand C, Licato LL et al. Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut 1998; 42:779-87.
43. Morise Z, Grisham MB. Molecular mechanisms involved in NSAID-induced gastropathy. J Clin Gastroenterol 1998; 27:S87-S90.
44. Farkas S, Herfarth H, Cuba M et al. ICAM-1 antibody treatment reduces leukocyte adherence and extravasation in DSS-induced colitis in mice: assessment by in vivo fluorescence microscopy. Langenbecks Arch Surg Suppl 1999; 1:403-6.
45. Dieleman LA, de Rover Z, Bloemena E et al. Effect of interleukin-10 in dextran sulfate sodium-induced colitis. Gastroenterology 1995; 110:A895(Abstr.).
46. Herfarth HH, Böcker U, Janardhanam R et al. Subtherapeutic corticosteroids potentiate the ability of interleukin-10 to prevent chronic inflammation in rats. Gastroenterology 1998; 115:1-11.
47. Farkas S, Herfarth H, Steinbauer M et al. In vivo fluorescence microscopy for assessment of leukocyte-endothelial interaction in the left colon in dextran sulphate sodium-induced colitis. Gastroenterology 1998; 114:A973(Abstr.).
48. Miagkov AV, Kovalenko DV, Brown CE et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998; 95:13859-64.